These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 27618142)

  • 21. Physician barriers to population-based, fecal occult blood test-based colorectal cancer screening programs for average-risk patients.
    McGregor S; Hilsden R; Yang H
    Can J Gastroenterol; 2010 Jun; 24(6):359-64. PubMed ID: 20559577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    Am J Gastroenterol; 2015 Dec; 110(12):1640-6. PubMed ID: 26169513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea.
    Bui NC; Cho HN; Lee YY; Suh M; Park B; Jun JK; Kim Y; Choi KS
    Cancer Res Treat; 2018 Apr; 50(2):416-427. PubMed ID: 28494531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in primary care physicians' colorectal cancer screening recommendations by patient age and comorbidity.
    Haggstrom DA; Klabunde CN; Smith JL; Yuan G
    J Gen Intern Med; 2013 Jan; 28(1):18-24. PubMed ID: 22653380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicians' use of nonphysician healthcare providers for colorectal cancer screening.
    Sansbury LB; Klabunde CN; Mysliwiec P; Brown ML
    Am J Prev Med; 2003 Oct; 25(3):179-86. PubMed ID: 14507523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
    Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported screening practices of family physicians participating in the colorectal cancer screening program of the canton of Vaud: a cross-sectional study.
    Poroes C; Cornuz J; Gouveia A; Ducros C; Selby K
    BMC Fam Pract; 2020 Jun; 21(1):103. PubMed ID: 32522159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The populations attitudes to colorectal cancer screening in the Czech Republic].
    Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
    Stock C; Ihle P; Schubert I; Brenner H
    Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening mode preferences among US veterans.
    Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
    Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician-patient colorectal cancer screening discussions by physicians' screening rates.
    O'Farrell CM; Green BB; Reid RJ; Bowen D; Baldwin LM
    J Am Board Fam Med; 2012; 25(6):771-81. PubMed ID: 23136315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.